Skip to main content
Log in

Progesterone levels in cesarean and normal delivered term placentas

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Background

One of the most important hormones synthesized by the placenta during pregnancy is progesterone. The regulating mechanisms of progesterone synthesis and the mechanism responsible for the spontaneous onset of labor in women are still not fully understood. Progesterone is thought to have been involved in human parturition. The objective of this study was to compare the levels of progesterone in the human placentas, at the end of the gestation (37–41 weeks) in vaginal versus cesarean deliveries, and to evaluate the pattern of progesterone accumulation, instantly following its synthesis by the human placenta at the end of the pregnancy.

Methods

Progesterone levels in human placental tissue were determined by immunochemiluminescent analysis, following tissue homogenization. Progesterone secretion and accumulation pattern in the placental tissue was demonstrated using the ex vivo, closed, dual perfusion system of isolated human placental cotyledon.

Results

Immunochemiluminescent analysis of progesterone levels in human normal and cesarean-delivered placentas showed that placentas following normal vaginal delivery store higher concentrations of progesterone, and produce progesterone more intensively. Results obtained from 120-min perfusions (of vaginal and cesarean-delivered placentas) showed that progesterone tended to accumulate in the maternal rather than the fetal compartment.

Conclusions

These data indicate that progesterone levels continuously rise till the end of pregnancy, with no apparent drop in progesterone levels during the labor process. In addition, progesterone is released from the syncytiotrophoblast preferably into the maternal component of the placental tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Weier N, He SM, Li XT, Wang LL, Zhou SF (2008) Placental drug disposition and its clinical implications. Curr Drug Metab 9:106–121. doi:10.2174/138920008783571828

    Article  CAS  PubMed  Google Scholar 

  2. Skałba P, Dabkowska-Huć A, Chełmicki Z (2003) The endocrinology of the human placenta. Wiad Lek 56:475–480

    PubMed  Google Scholar 

  3. Speroff L, Fritz MA (2005) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Philadelphia

  4. Denschlag D, Keck C (2002) The corpus luteum. Ther Umsch 59:159–162. doi:10.1024/0040-5930.59.4.159

    Article  CAS  PubMed  Google Scholar 

  5. Grow DR (2002) Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 29:425–436. doi:10.1016/S0889-8545(02)00009-8

    Article  PubMed  Google Scholar 

  6. Critchley HOD, Kelly RW, Brenner RM, Baird DT (2003) Antiprogestins as a model for progesterone withdrawal. Steroids 68:1061–1068. doi:10.1016/j.steroids.2003.07.001

    Article  CAS  PubMed  Google Scholar 

  7. Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres-Bartho J (2007) Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol 58:268–279. doi:10.1111/j.1600-0897.2007.00512.x

    Article  CAS  PubMed  Google Scholar 

  8. Tuckey RC (2005) Progesterone synthesis by the human placenta. Placenta 26:273–281. doi:10.1016/j.placenta.2004.06.012

    Article  CAS  PubMed  Google Scholar 

  9. Miyaura H, Iwata M (2002) Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 168:1087–1094

    CAS  PubMed  Google Scholar 

  10. Shanker YG, Shetty UP, Rao AJ (1998) Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta. Mol Cell Biochem 187:133–139. doi:10.1023/A:1006843812495

    Article  CAS  PubMed  Google Scholar 

  11. Pasqualini JR (2005) Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 97:401–415. doi:10.1016/j.jsbmb.2005.08.004

    Article  CAS  PubMed  Google Scholar 

  12. Bernal AL (2001) Overview of current research in parturition. Exp Physiol 86:213–222. doi:10.1113/eph8602178

    Article  CAS  PubMed  Google Scholar 

  13. Smith R (2007) Parturition. N Engl J Med 356:271–283. doi:10.1056/NEJMra061360

    Article  CAS  PubMed  Google Scholar 

  14. Mesiano S (2004) Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11:193–202. doi:10.1016/j.jsgi.2003.12.004

    Article  CAS  PubMed  Google Scholar 

  15. Thijssen JH (2005) Progesterone receptors in the human uterus and their possible role in parturition. J Steroid Biochem Mol Biol 97:397–400. doi:10.1016/j.jsbmb.2005.08.011

    Article  CAS  PubMed  Google Scholar 

  16. Mesiano S (2007) Myometrial progesterone responsiveness. Semin Reprod Med 25:5–13. doi:10.1055/s-2006-956771

    Article  CAS  PubMed  Google Scholar 

  17. Zakar T, Hertelendy F (2007) Progesterone withdrawal: key to parturition. Am J Obstet Gynecol 196:289–296. doi:10.1016/j.ajog.2006.09.005

    Article  CAS  PubMed  Google Scholar 

  18. Sheehan PM, Rice GE, Moses EK, Brennecke SP (2005) 5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term. Mol Hum Reprod 11:495–501. doi:10.1093/molehr/gah201

    Article  CAS  PubMed  Google Scholar 

  19. Schneider H, Huch A (1985) Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet 13:40–47

    CAS  PubMed  Google Scholar 

  20. Myren M, Mose T, Mathiesen L, Knudsen LE (2007) The human placenta—an alternative for studying foetal exposure. Toxicol In Vitro 21:1332–1340. doi:10.1016/j.tiv.2007.05.011

    Article  CAS  PubMed  Google Scholar 

  21. Holcberg G, Sapir O, Tsadkin M, Huleihel M, Lazer S, Katz M, Mazor M, Ben-Zvi Z (2003) Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 109:133–137. doi:10.1016/S0301-2115(02)00513-4

    Article  CAS  PubMed  Google Scholar 

  22. Kopecky EA, Simone C, Knie B, Koren G (1999) Transfer of morphine across the human placenta and its interaction with naloxone. Life Sci 65:2359–2377. doi:10.1016/S0024-3205(99)00503-2

    Article  CAS  PubMed  Google Scholar 

  23. Shargel L, Cheung WM, Yu AB (1979) High-pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci 68:1052–1054. doi:10.1002/jps.2600680835

    Article  CAS  PubMed  Google Scholar 

  24. Löfgren M, Bäckström T (1997) High progesterone is related to effective human labor. Study of serum progesterone and 5 alpha-pregnane-3, 20-dione in normal and abnormal deliveries. Acta Obstet Gynecol Scand 76:423–430. doi:10.3109/00016349709047823

    Article  PubMed  Google Scholar 

  25. Maynard PV, Stein PE, Symonds EM (1980) Umbilical cord plasma progesterone at term in relation to mode of delivery. Br J Obstet Gynaecol 87:864–868

    CAS  PubMed  Google Scholar 

  26. Aisien AO, Towobola OA, Otubu JA, Imade GE (1994) Umbilical cord venous progesterone at term delivery in relation to mode of delivery. Int J Gynaecol Obstet 47:27–31. doi:10.1016/0020-7292(94)90457-X

    Article  CAS  PubMed  Google Scholar 

  27. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R (2002) Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 87:2924–2930. doi:10.1210/jc.87.6.2924

    Article  CAS  PubMed  Google Scholar 

  28. Fortson J, Howe L, Harmon C, Sherrill WW (2008) Targeting cardiovascular risk: early identification of insulin resistance. J Am Acad Nurse Pract 20:319–325. doi:10.1111/j.1745-7599.2008.00324.x

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Valeria Feinshtein or Gershon Holcberg.

Additional information

Z. Ben-Zvi, G. Holcberg are equally contributed to this study.

Authors’ contributions: VF carried out the tissue processing, the perfusion experiments and wrote the manuscript. AA participated and advised throughout the perfusion experiments. BS was the connecting person with the delivery room and supplied the placentas. ES provided consultation regarding the statistical analysis and revised the manuscript. ZBZ and GH managed the project and revised the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feinshtein, V., Ben-Zvi, Z., Sheiner, E. et al. Progesterone levels in cesarean and normal delivered term placentas. Arch Gynecol Obstet 281, 387–392 (2010). https://doi.org/10.1007/s00404-009-1125-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-009-1125-x

Keywords

Navigation